After two years of planning and waiting on regulatory approvals, Massachusetts-based AquaBounty Technologies Inc. (Nasdaq: AQB) has begun commercial production of its AquAdvantage Salmon at its Albany facility. The announcement comes three months after the U.S. Food and Drug Administration lifted an Import Alert that prevented the company from shipping its salmon eggs from Canada.

AquaBounty took over control of the facility after acquiring Bell Fish Co. in a $14 million deal in 2017. The company received FDA approval in April 2018 to raise salmon at the facility, but had to wait until the Import Alert was lifted to begin producing its branded salmon. While it waited, the company stocked the facility with traditional Atlantic salmon.  Read the article.

Share